SCHEMBL17375554

SCHEMBL17375554

CC(C)(CN)c1cccc(OCc2ccccc2)c1

nearest known ligand 0.55

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
MAOB P27338 6/20 0.55
TAAR1 Q96RJ0 1/20 0.53
PKM P14618 1/20 0.51
BCHE P06276 2/20 0.49
CYP4F2 P78329 1/20 0.49
CYP4A11 Q02928 1/20 0.49
NR4A2 P43354 2/20 0.48
MAOA P21397 1/20 0.48
CACNA1B Q00975 1/20 0.47
NR4A1 P22736 1/20 0.47
NR4A3 Q92570 1/20 0.47
ALOX5 P09917 1/20 0.46
MRGPRX4 Q96LA9 1/20 0.46
LCK P06239 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10474017 0.86 MAOB (0.60) MAOBPKMBCHECYP4F2CYP4A11
SCHEMBL13254878 0.85 MAOB (0.59) MAOBPKMBCHECYP4F2CYP4A11
SCHEMBL15650460 0.84 MAOB (0.58) MAOBPKMBCHECYP4F2CYP4A11
SCHEMBL78171 0.84 MAOB (0.62) MAOBPKMBCHECYP4F2CYP4A11
SCHEMBL5321852 0.83 TAAR1 (0.58) MAOBTAAR1BCHENR4A2MAOA
SCHEMBL10472144 0.81 MAOB (0.58) MAOBPKMBCHECYP4F2CYP4A11
SCHEMBL9434943 0.81 MAOB (0.58) MAOBPKMBCHECYP4F2CYP4A11
SCHEMBL13930902 0.80 MAOB (0.57) MAOBPKMBCHECYP4F2CYP4A11
SCHEMBL27816667 0.80 MAOB (0.57) MAOBPKMBCHECYP4F2CYP4A11
Formaldehyde SCHEMBL27492762 0.80 NR4A2 (0.58) MAOBPKMBCHECYP4F2CYP4A11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015197550-A1 NOVEL DIHYDROPYRIDOISOQUINOLINONES AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS GALAPAGOS NV (BE) 2015-12-30 WO disclosed
WO-2015197550-A1 NOVEL DIHYDROPYRIDOISOQUINOLINONES AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS GALAPAGOS NV (BE) 2015-12-30 WO disclosed